X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3130) 3130
Publication (212) 212
Book Review (63) 63
Book Chapter (13) 13
Conference Proceeding (4) 4
Dissertation (2) 2
Magazine Article (2) 2
Book / eBook (1) 1
Data Set (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2452) 2452
index medicus (2283) 2283
rivaroxaban (1676) 1676
anticoagulants (1322) 1322
male (984) 984
administration, oral (889) 889
warfarin (874) 874
female (855) 855
anticoagulants - therapeutic use (852) 852
dabigatran (833) 833
factor xa inhibitors (831) 831
venous thromboembolism (768) 768
hematology (706) 706
aged (672) 672
factor xa inhibitor (669) 669
atrial fibrillation (657) 657
apixaban (650) 650
anticoagulants - administration & dosage (648) 648
peripheral vascular disease (630) 630
anticoagulants - adverse effects (615) 615
factor xa inhibitors - therapeutic use (602) 602
middle aged (589) 589
prevention (584) 584
treatment outcome (536) 536
cardiac & cardiovascular systems (521) 521
stroke (511) 511
thromboembolism (509) 509
hemorrhage - chemically induced (504) 504
atrial fibrillation - drug therapy (491) 491
pharmacology & pharmacy (476) 476
thrombin (464) 464
factor-xa inhibitor (448) 448
stroke - prevention & control (445) 445
factor xa inhibitors - administration & dosage (429) 429
atrial-fibrillation (425) 425
dabigatran etexilate (424) 424
factor xa inhibitors - adverse effects (415) 415
risk factors (409) 409
rivaroxaban - therapeutic use (392) 392
thrombosis (382) 382
atrial fibrillation - complications (376) 376
blood coagulation - drug effects (369) 369
double-blind (352) 352
safety (351) 351
pharmacokinetics (341) 341
adult (335) 335
animals (332) 332
anticoagulants - pharmacology (326) 326
abridged index medicus (324) 324
oral anticoagulants (323) 323
anticoagulation (320) 320
morpholines - therapeutic use (320) 320
thiophenes - therapeutic use (317) 317
deep-vein thrombosis (309) 309
direct thrombin inhibitor (302) 302
enoxaparin (300) 300
aged, 80 and over (297) 297
analysis (292) 292
pyrazoles - therapeutic use (285) 285
pyridones - therapeutic use (283) 283
medicine, general & internal (275) 275
rivaroxaban - administration & dosage (275) 275
drug therapy (272) 272
edoxaban (271) 271
venous thromboembolism - prevention & control (269) 269
pharmacodynamics (266) 266
thromboprophylaxis (261) 261
medicine & public health (258) 258
bleeding (257) 257
rivaroxaban - adverse effects (253) 253
management (252) 252
factor xa (250) 250
stroke - etiology (249) 249
morpholines - administration & dosage (245) 245
thiophenes - administration & dosage (245) 245
warfarin - therapeutic use (245) 245
vitamin k - antagonists & inhibitors (244) 244
venous thromboembolism - drug therapy (242) 242
care and treatment (241) 241
risk (239) 239
dose-response relationship, drug (236) 236
pyridones - administration & dosage (229) 229
pyrazoles - administration & dosage (227) 227
stroke prevention (222) 222
in-vitro (220) 220
surgery (211) 211
hemorrhage (202) 202
prothrombin complex concentrate (199) 199
antithrombotic therapy (198) 198
morpholines - adverse effects (197) 197
molecular-weight heparin (196) 196
thiophenes - adverse effects (196) 196
cardiology (193) 193
therapy (192) 192
dosage and administration (191) 191
anticoagulants - pharmacokinetics (188) 188
direct oral anticoagulants (188) 188
beta-alanine - analogs & derivatives (187) 187
patients (187) 187
anticoagulant (183) 183
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2928) 2928
German (65) 65
French (52) 52
Japanese (36) 36
Russian (25) 25
Spanish (20) 20
Polish (8) 8
Czech (7) 7
Portuguese (7) 7
Hungarian (6) 6
Italian (5) 5
Chinese (3) 3
Swedish (3) 3
Danish (2) 2
Norwegian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 01/2011, Volume 9, Issue 1, pp. 133 - 139
Journal Article
Circulation, ISSN 0009-7322, 11/2006, Volume 114, Issue 22, pp. 2374 - 2381
Background - Rivaroxaban (BAY 59-7939) -an oral, direct Factor Xa inhibitor-could be an alternative to heparins and warfarin for the prevention and treatment... 
Prevention | Anticoagulants | Thrombosis | Embolism | Coagulation | ENOXAPARIN | XIMELAGATRAN | CARDIAC & CARDIOVASCULAR SYSTEMS | DIRECT THROMBIN INHIBITOR | embolism | coagulation | POSTOPERATIVE FONDAPARINUX | thrombosis | KNEE REPLACEMENT | VENOUS THROMBOEMBOLISM | DABIGATRAN ETEXILATE | PHARMACOKINETICS | anticoagulants | PERIPHERAL VASCULAR DISEASE | II RANDOMIZED-TRIAL | prevention | Thiophenes - therapeutic use | Anticoagulants - administration & dosage | Double-Blind Method | Drug Administration Schedule | Factor Xa Inhibitors | Administration, Oral | Humans | Middle Aged | Morpholines - administration & dosage | Postoperative Complications - prevention & control | Anticoagulants - therapeutic use | Male | Hemorrhage - prevention & control | Thiophenes - administration & dosage | Rivaroxaban | Sample Size | Survival Analysis | Postmenopause | Adult | Arthroplasty, Replacement, Hip - mortality | Female | Safety | Morpholines - therapeutic use | Postoperative Complications/prevention & control | Administration | Anticoagulants/administration & dosage/therapeutic use | Morpholines/administration & dosage/therapeutic use | Arthroplasty | Replacement | Thiophenes/administration & dosage/therapeutic use | Oral | Kirurgi | Hemorrhage/prevention & control | Surgery | Hip/mortality | Factor Xa/antagonists & inhibitors
Journal Article
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 04/2013, Volume 52, Issue 4, pp. 243 - 254
The direct factor Xa (FXa) inhibitors rivaroxaban, apixaban and edoxaban, and the thrombin inhibitor dabigatran etexilate (dabigatran) have gained approval for... 
UNITED-STATES | IN-VITRO | BAY-59-7939 | VENOUS THROMBOEMBOLISM | PHARMACOKINETICS | SAFETY | COAGULATION DISORDERS | PHARMACOLOGY & PHARMACY | PHARMACODYNAMICS | STAGE LIVER-DISEASE | RENAL IMPAIRMENT | Thiophenes - therapeutic use | Pyrazoles - therapeutic use | Anticoagulants - administration & dosage | Factor Xa Inhibitors | Humans | Thrombin - antagonists & inhibitors | Pyridines - pharmacokinetics | Metabolic Clearance Rate | Thiazoles - administration & dosage | Thiophenes - administration & dosage | Dabigatran | Thiazoles - therapeutic use | Thiazoles - pharmacokinetics | Venous Thromboembolism - blood | Dose-Response Relationship, Drug | Tissue Distribution | Pyridones - administration & dosage | Rivaroxaban | Venous Thromboembolism - prevention & control | Absorption | Benzimidazoles - administration & dosage | Venous Thromboembolism - complications | Liver Diseases - complications | Pyrazoles - pharmacokinetics | Morpholines - therapeutic use | Benzimidazoles - therapeutic use | Pyridines - therapeutic use | Pyridines - administration & dosage | Pyridones - pharmacokinetics | Morpholines - administration & dosage | Benzimidazoles - pharmacokinetics | Anticoagulants - therapeutic use | Thiophenes - pharmacokinetics | Pyrazoles - administration & dosage | Anticoagulants - pharmacokinetics | Pyridones - therapeutic use | Morpholines - pharmacokinetics | Liver Diseases - metabolism
Journal Article
Journal Article
Medical Journal of Australia, ISSN 0025-729X, 04/2009, Volume 190, Issue 7, pp. 379 - 383
Journal Article
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2012, Volume 366, Issue 14, pp. 1287 - 1297
Journal Article